Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
134.92
+1.75 (1.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 131.41, with a low estimate of 117 and a high estimate of 158. The average target predicts a decrease of -2.60% from the current stock price of 134.92.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Abbott Laboratories stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 4 | 5 | 5 |
Buy | 6 | 8 | 8 | 8 | 8 | 8 |
Hold | 2 | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 16 | 16 | 16 | 17 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Buy Maintains $149 → $158 | Buy | Maintains | $149 → $158 | +17.11% | Jan 27, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $135 | Buy | Reiterates | $135 | +0.06% | Jan 23, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $133 → $136 | Buy | Maintains | $133 → $136 | +0.80% | Jan 23, 2025 |
Stifel | Stifel | Strong Buy Maintains $130 → $135 | Strong Buy | Maintains | $130 → $135 | +0.06% | Jan 23, 2025 |
UBS | UBS | Strong Buy Maintains $146 → $148 | Strong Buy | Maintains | $146 → $148 | +9.69% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
44.77B
from 41.95B
Increased by 6.71%
Revenue Next Year
48.10B
from 44.77B
Increased by 7.45%
EPS This Year
5.21
from 7.64
Decreased by -31.85%
EPS Next Year
5.76
from 5.21
Increased by 10.61%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 47.7B | 51.9B | 56.3B | ||
Avg | 44.8B | 48.1B | 51.6B | ||
Low | 43.1B | 45.7B | 49.0B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.7% | 15.9% | 17.0% | ||
Avg | 6.7% | 7.4% | 7.4% | ||
Low | 2.7% | 2.2% | 1.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5.49 | 6.20 | 6.99 | ||
Avg | 5.21 | 5.76 | 6.38 | ||
Low | 4.97 | 5.41 | 5.85 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -28.1% | 19.0% | 21.4% | ||
Avg | -31.8% | 10.6% | 10.9% | ||
Low | -35.0% | 3.9% | 1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.